Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

USA - NYSE:IBTA - US4510511060 - Common Stock

29.92 USD
+0.99 (+3.42%)
Last: 10/3/2025, 8:04:01 PM
29.92 USD
0 (0%)
After Hours: 10/3/2025, 8:04:01 PM
Fundamental Rating

4

Overall IBTA gets a fundamental rating of 4 out of 10. We evaluated IBTA against 98 industry peers in the Media industry. IBTA has an excellent financial health rating, but there are some minor concerns on its profitability. IBTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

IBTA had positive earnings in the past year.
In the past year IBTA had a positive cash flow from operations.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

IBTA's Return On Assets of 16.06% is amongst the best of the industry. IBTA outperforms 97.96% of its industry peers.
With an excellent Return On Equity value of 27.24%, IBTA belongs to the best of the industry, outperforming 91.84% of the companies in the same industry.
The Return On Invested Capital of IBTA (7.48%) is better than 77.55% of its industry peers.
Industry RankSector Rank
ROA 16.06%
ROE 27.24%
ROIC 7.48%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 -50 100 150

1.3 Margins

The Profit Margin of IBTA (26.24%) is better than 95.92% of its industry peers.
IBTA has a Operating Margin of 9.33%. This is comparable to the rest of the industry: IBTA outperforms 59.18% of its industry peers.
IBTA's Gross Margin of 83.04% is amongst the best of the industry. IBTA outperforms 95.92% of its industry peers.
Industry RankSector Rank
OM 9.33%
PM (TTM) 26.24%
GM 83.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBTA is destroying value.
Compared to 1 year ago, IBTA has more shares outstanding
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

IBTA has an Altman-Z score of 3.04. This indicates that IBTA is financially healthy and has little risk of bankruptcy at the moment.
IBTA's Altman-Z score of 3.04 is amongst the best of the industry. IBTA outperforms 80.61% of its industry peers.
There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.04
ROIC/WACC0.86
WACC8.67%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.37 indicates that IBTA has no problem at all paying its short term obligations.
IBTA has a Current ratio of 2.37. This is amongst the best in the industry. IBTA outperforms 80.61% of its industry peers.
IBTA has a Quick Ratio of 2.37. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA's Quick ratio of 2.37 is amongst the best of the industry. IBTA outperforms 80.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.37
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

IBTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.05%, which is quite impressive.
IBTA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.75%.
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.06%
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.16%

3.2 Future

The Earnings Per Share is expected to decrease by -17.39% on average over the next years. This is quite bad
The Revenue is expected to grow by 0.38% on average over the next years.
EPS Next Y-50.92%
EPS Next 2Y-65.42%
EPS Next 3Y-17.39%
EPS Next 5YN/A
Revenue Next Year-9.52%
Revenue Next 2Y-4.12%
Revenue Next 3Y0.38%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.1 -0.1 0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

IBTA is valuated rather expensively with a Price/Earnings ratio of 22.67.
68.37% of the companies in the same industry are more expensive than IBTA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.86. IBTA is around the same levels.
IBTA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 22.67
Fwd PE N/A
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IBTA.
Based on the Price/Free Cash Flow ratio, IBTA is valued a bit cheaper than 75.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.46
EV/EBITDA 13.29
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as IBTA's earnings are expected to decrease with -17.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-65.42%
EPS Next 3Y-17.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IBTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (10/3/2025, 8:04:01 PM)

After market: 29.92 0 (0%)

29.92

+0.99 (+3.42%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-13 2025-11-13
Inst Owners52.81%
Inst Owner Change-18.03%
Ins Owners7.1%
Ins Owner Change-0.3%
Market Cap849.73M
Analysts52.86
Price Target31.04 (3.74%)
Short Float %18.4%
Short Ratio4.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)126.15%
Min EPS beat(2)-59.33%
Max EPS beat(2)311.64%
EPS beat(4)3
Avg EPS beat(4)85.34%
Min EPS beat(4)-59.33%
Max EPS beat(4)311.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.89%
Min Revenue beat(2)-6.83%
Max Revenue beat(2)1.04%
Revenue beat(4)2
Avg Revenue beat(4)-2.48%
Min Revenue beat(4)-6.93%
Max Revenue beat(4)2.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-49.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)-88.25%
EPS NY rev (3m)-91.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.43%
Revenue NY rev (1m)-4.48%
Revenue NY rev (3m)-12.43%
Valuation
Industry RankSector Rank
PE 22.67
Fwd PE N/A
P/S 2.31
P/FCF 9.46
P/OCF 7.92
P/B 2.4
P/tB 2.4
EV/EBITDA 13.29
EPS(TTM)1.32
EY4.41%
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)3.16
FCFY10.58%
OCF(TTM)3.78
OCFY12.62%
SpS12.94
BVpS12.47
TBVpS12.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.06%
ROE 27.24%
ROCE 8.65%
ROIC 7.48%
ROICexc 20.31%
ROICexgc 20.31%
OM 9.33%
PM (TTM) 26.24%
GM 83.04%
FCFM 24.45%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 200.53%
Cap/Sales 4.73%
Interest Coverage 188.53
Cash Conversion 249.53%
Profit Quality 93.17%
Current Ratio 2.37
Quick Ratio 2.37
Altman-Z 3.04
F-Score7
WACC8.67%
ROIC/WACC0.86
Cap/Depr(3y)126.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.06%
EPS Next Y-50.92%
EPS Next 2Y-65.42%
EPS Next 3Y-17.39%
EPS Next 5YN/A
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.16%
Revenue Next Year-9.52%
Revenue Next 2Y-4.12%
Revenue Next 3Y0.38%
Revenue Next 5YN/A
EBIT growth 1Y-50.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.06%
EBIT Next 3Y27.99%
EBIT Next 5YN/A
FCF growth 1Y629.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y410.29%
OCF growth 3YN/A
OCF growth 5YN/A